AEON Biopharma, Inc. 10-K filing
Filed 2026-03-30 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001837607-26-000019
- Form type
- 10-K
- CIK
- 0001837607
- Primary document
- https://www.sec.gov/Archives/edgar/data/1837607/000183760726000019/aeon-20251231x10k.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for AEON Biopharma, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-12.8M | - | - |
| Net Income | $-39.2M | - | - |
| Eps Basic | -3.95 | - | - |
| Eps Diluted | -3.95 | - | - |
| Cash And Equivalents | $3.0M | - | - |
| Total Assets | $5.6M | - | - |
| Total Liabilities | $60.6M | - | - |
| Operating Cash Flow | $-17.3M | - | - |
| Capital Expenditures | $4,000 | - | - |